Belfast · Northern Ireland
TheBELFAST HERALDLocal knowledge. National perspective.
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works
HealthPremium archive

Malaysia signs an agreement with Merck & Co. to obtain 150,000 courses of the experimental drug Molnupiravir

Malaysia signs an agreement with Merck & Co. to obtain 150,000 courses of the experimental drug Molnupiravir as part of a transition towards the endemic phase and "living with the COVID-19".

By Belfast Herald Newsdesk1 min read

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthMalaysia signs an agreement with Merck & Co. to obtain 150,000 courses of the experimental drug Molnupiravir

Malaysia signs an agreement with Merck & Co. to obtain 150,000 courses of the experimental drug Molnupiravir as part of a transition towards the endemic phase and "living with the COVID-19".

View Premium plansBrowse free archive reports